Intuitive Surgical benefits from a strong, recurring revenue model centered on its installed base of robotic surgery systems, which now totals over 12,000 units globally. Its revenue is increasingly driven by proprietary instruments and service contracts, making it resilient to economic cycles and recessions. The company also strengthens growth through significant share buybacks and maintains a robust balance sheet with nearly $8 billion in cash. Despite recent share price declines due to tariff concerns and potential hospital spending freezes, Intuitive's long-term growth outlook remains solid, supported by rising healthcare demand and procedure volumes.
Agility Robotics, led by CEO Peggy Johnson, announced it will go public through a SPAC merger with Churchill Capital Corp., becoming the first pure-play humanoid robotics company to enter public markets. The company’s humanoid robot, Digit, is alread...
The Global X Robotics & Artificial Intelligence ETF (BOTZ) is a leading U.S.-listed fund providing access to global robotics and AI companies, including major foreign automation firms and U.S. AI chipmakers. It offers investors diversified exposure t...
